• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B型利钠肽在慢性阻塞性肺疾病(COPD)和慢性心力衰竭中的诊断价值及肌肉改变的功能后果

Diagnostic usefulness of B-type natriuretic peptide and functional consequences of muscle alterations in COPD and chronic heart failure.

作者信息

Jelic Sanja, Le Jemtel Thierry H

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, PH 8, Room 840, 630 West 168th St, New York, NY 10032, USA.

出版信息

Chest. 2006 Oct;130(4):1220-30. doi: 10.1378/chest.130.4.1220.

DOI:10.1378/chest.130.4.1220
PMID:17035459
Abstract

COPD affects up to one third of patients with chronic heart failure. The coexistence of COPD and chronic heart failure presents clinicians with diagnostic and therapeutic challenges. Measurement of B-type natriuretic peptide plasma levels facilitates the diagnosis of acute dyspnea in patients known to have both COPD and chronic heart failure. Patients with COPD or chronic heart failure have skeletal muscle abnormalities that limit functional capacity independently from primary organ failure. Exercise training reverses skeletal muscle abnormalities in patients with COPD or chronic heart failure and may be particularly indicated in patients with coexistent COPD and chronic heart failure.

摘要

慢性阻塞性肺疾病(COPD)影响多达三分之一的慢性心力衰竭患者。COPD与慢性心力衰竭并存给临床医生带来了诊断和治疗方面的挑战。测量B型利钠肽血浆水平有助于诊断已知患有COPD和慢性心力衰竭的患者的急性呼吸困难。COPD或慢性心力衰竭患者存在骨骼肌异常,这独立于原发性器官衰竭限制了功能能力。运动训练可逆转COPD或慢性心力衰竭患者的骨骼肌异常,对于COPD和慢性心力衰竭并存的患者可能特别适用。

相似文献

1
Diagnostic usefulness of B-type natriuretic peptide and functional consequences of muscle alterations in COPD and chronic heart failure.B型利钠肽在慢性阻塞性肺疾病(COPD)和慢性心力衰竭中的诊断价值及肌肉改变的功能后果
Chest. 2006 Oct;130(4):1220-30. doi: 10.1378/chest.130.4.1220.
2
Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.老年人中慢性阻塞性肺疾病与心力衰竭并存
Int J Cardiol. 2008 Apr 10;125(2):209-15. doi: 10.1016/j.ijcard.2007.12.001. Epub 2008 Jan 24.
3
Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease.B型利钠肽检测用于在临床诊断为慢性阻塞性肺疾病的稳定老年患者中识别心力衰竭的比较
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):651-9. doi: 10.1016/j.ejheart.2007.01.010. Epub 2007 Mar 7.
4
Serum brain natriuretic peptide level in a patient with chronic obstructive pulmonary disease and chronic heart failure.慢性阻塞性肺疾病合并慢性心力衰竭患者的血清脑钠肽水平
Congest Heart Fail. 2004 Mar-Apr;10(2):106-8. doi: 10.1111/j.1527-5299.2004.03248.x.
5
Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.慢性阻塞性肺疾病和慢性心力衰竭并存患者的诊断和治疗挑战
J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. doi: 10.1016/j.jacc.2006.08.046. Epub 2006 Dec 29.
6
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.B型利钠肽在心力衰竭急诊诊断中的快速测定
N Engl J Med. 2002 Jul 18;347(3):161-7. doi: 10.1056/NEJMoa020233.
7
[Performance of natriuretic peptide as a marker in patients with chronic obstructive pulmonary disease].[利钠肽作为慢性阻塞性肺疾病患者标志物的性能]
Rev Med Suisse. 2012 Oct 17;8(358):1961-2, 1964-5.
8
Utility of N-terminal pro B-type natriuretic peptide and mean platelet volume in differentiating congestive heart failure from chronic obstructive pulmonary disease.
Int J Cardiol. 2013 Dec 10;170(2):e28-9. doi: 10.1016/j.ijcard.2013.10.048. Epub 2013 Oct 16.
9
B-type natriuretic peptide: a new measurement to distinguish cardiac from pulmonary causes of acute dyspnea.B型利钠肽:一种区分急性呼吸困难心脏病因与肺病因的新检测方法。
J Emerg Nurs. 2005 Feb;31(1):73-5; quiz 119-20. doi: 10.1016/j.jen.2004.06.017.
10
Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.氨基末端脑钠肽前体用于诊断既往有阻塞性气道疾病患者的急性心力衰竭。
Ann Emerg Med. 2006 Jul;48(1):66-74. doi: 10.1016/j.annemergmed.2005.12.022. Epub 2006 Feb 17.

引用本文的文献

1
Mortality in Advanced Chronic Obstructive Pulmonary Disease and Heart Failure Following Cardiopulmonary Rehabilitation.心肺康复后晚期慢性阻塞性肺疾病和心力衰竭患者的死亡率
Biol Res Nurs. 2018 Jul;20(4):429-439. doi: 10.1177/1099800418772346. Epub 2018 Apr 29.
2
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.慢性阻塞性肺疾病中的B型利钠肽:一项系统评价
BMC Pulm Med. 2017 Jan 10;17(1):11. doi: 10.1186/s12890-016-0345-7.
3
Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community.
社区中合并慢性阻塞性肺疾病的心力衰竭患者的短期预后
World J Cardiol. 2012 Mar 26;4(3):66-71. doi: 10.4330/wjc.v4.i3.66.
4
N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment.
Sleep Breath. 2008 Mar;12(1):3-5. doi: 10.1007/s11325-007-0144-8.